Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung Sort descending
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Sort descending Site Standort Division Business Functional Area Erscheinungsdatum
Sr. Manager DDIT GF Sol.Del. China Shanghai (Shanghai) China Operations CTS Technology Transformation Sep 03, 2024
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Sr. Medical Science Liaison, ASCVD Seoul Südkorea International Innovative Medicines Research & Development Sep 05, 2024
Sr. Mgr. DDIT Sol.Del. China Data Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Svc.Mgt CN Data Platf Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Process Team Lead İstanbul Kurtköy Türkei Operations Innovative Medicines Technical Operations Sep 03, 2024
Sr. Procurement Specialist, TPRM Hyderabad (Office) Indien Operations CTS Beschaffung Jul 23, 2024
Sr. Spec. Cloud Infrastructure Solution Delivery - Global Drug Development INSURGENTES Mexiko Operations CTS Technology Transformation Okt 22, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 10, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 11, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Database Services INSURGENTES Mexiko Operations CTS Technology Transformation Aug 27, 2024
Sr. Spec. DDIT IES DB & MW Services-IES- Cloud Platform Svcs Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 19, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 22, 2024
Sr. Spec. DDIT IES O365 Sec. & Compl. Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 09, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 10, 2024
Sr. Spec. DDIT IES Solution Delivery INSURGENTES Mexiko Operations CTS Technology Transformation Okt 03, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) Indien Operations CTS Informationstechnologie Okt 18, 2024
Sr. Spec. DDIT IES Workforce Mgmt. Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 03, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 20, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 21, 2024
Sr. Spec. DDIT ISC QNova Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 24, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 07, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexiko Operations CTS Informationstechnologie Jul 15, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 29, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 23, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Prague Tschechische Republik Operations CTS Technology Transformation Okt 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 07, 2024
Sr. Specialist DDIT ISC CSOC Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Sep 26, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 17, 2024
Sr. Specialist Qualification Engineer INSURGENTES Mexiko Operations CTS Technology Transformation Sep 11, 2024
Sr. Specialist Quality Management Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 21, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 18, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Sr.Territory Business Executive Madhya Pradesh Indien International Innovative Medicines Der Umsatz Okt 03, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 21, 2024
SSO Finance Specialist İstanbul Kavacık Türkei Development Innovative Medicines Research & Development Sep 10, 2024
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Okt 20, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) China Development Innovative Medicines Research & Development Sep 17, 2024
SSO Study Start-Up Manager Mapletree Business City (MBC) Singapur Development Innovative Medicines Research & Development Okt 21, 2024
SSU Manager INSURGENTES Mexiko Development Innovative Medicines Research & Development Okt 15, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spanien Operations CTS Marketing Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.